ImmunoRx Pharma
Wilmington, US · Founded 2020 · Delaware corporation
Founders & leadership
CF
Caroline FortierNamed on SEC filing
MC
Mark CiprianoNamed on SEC filing
MR
Marc RiviereNamed on SEC filing
PT
Philippe TessierNamed on SEC filing
AL
Alexandre LebeautNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$2.7M disclosed across 1 round · 2020
▶$2.7MraisedFeb 2021 · 2 investors · PharmaceuticalsRule 506(b)
▶$2.7MraisedFeb 2021 · 2 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Caroline FortierExecutive Officer
- Mark CiprianoExecutive Officer
- Marc RiviereDirector
- Philippe TessierDirector
- Alexandre LebeautDirector
- Offering amount
- $25.4M
- Amount sold
- $2.7M
- Proceeds to insiders
- $86K
- First sale
- Nov 2020
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has ImmunoRx Pharma raised?
- ImmunoRx Pharma has disclosed $2.7M raised across 1 round.
- Where is ImmunoRx Pharma headquartered?
- ImmunoRx Pharma is headquartered in Wilmington, US.